AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Immunization With Alum Allows Manipulation Of T-cell Response.(Brief Article)

Vaccine Weekly

| July 04, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 JUL 4 - (NewsRx.com & NewsRx.net) --

by N.R. Saltmarsh, staff medical writer - Mice immunized with Porphyromonas gingivalis in alum adjuvant have higher antibody response to P. gingivalis infection than unimmunized mice, say researchers working in Israel.

"The present study was designed to examine the effect of immunization on the local cellular, cytokine and antibody response to P. gingivalis in mice," reported Y. Houri-Haddad and colleagues at Hebrew University.

They tested the potential of a P. gingivalis vaccine to control periodontitis in three groups of mice: one immunized with P. gingivalis plus incomplete Freund's adjuvant (IFA), one immunized with P. gingivalis plus alum, and one unimmunized to serve as controls.

Researchers challenged mice with infection through previously implanted subcutaneous chambers at baseline (day 0) then tested chamber exudate for the presence of leukocytes and the cytokines tumor necrosis factor (TNF-)alpha, interferon (IFN)gamma (pro-inflammatory) and interleukin (IL)-10 (anti-inflammatory) on days 0, 1, and 7 post-immunization, said Houri-Haddad and coworkers. The researchers also measured immunoglobulin G (IgG) in both exudates and sera.

Their findings were as follows:

* Leukocyte counts increased over the study period and were greater in the immunized mice

Related articles from newspapers, magazines, journals, and more
Poxvirus used for delivery of stimulatory molecules to melanoma tumors.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Delivery, Skin Cancer, Dermatology, Immunotherapy, Vaccine Development, and Oncology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Broadly cross-reactive HIV-neutralizing antibody Fab identified.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Therapy, Vaccine Development, Monoclonal Antibodies, Diagnostics, and Immunotherapy. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Arginine-glysine-aspartate motif enhances immunogenicity of antigens.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Delivery, Vaccine Development, Vaccine Efficacy, Immunology, and Immunotherapy. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Cancer vaccine using low affinity epitopes proves successful in mice.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...This article may be viewed at https://www.the-jci.org/press/19418.pdf. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
DNA induces T helper type 1-mediated responses in antigen-primed mice.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Bacteriology, Biological Therapy, Immunology, Immunotherapy, Oncology, and Proteomics. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Researcher reviews novel cancer vaccines.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Vaccine Development, Vaccine Efficacy, Immunotherapy, Proteomics, and Oncology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Call for increase in flu vaccination among young children.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...administration should make it possible to increase the use of influenza vaccination." This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Positive results of cholera vaccine trial in Bangladesh reported.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...vaccines against anthrax or other organisms that might be used as biowarfare agents. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Typhoid/hepatitis A vaccine effective as booster dose in primed adults.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Vaccine Efficacy, Vaccine Development, Hepatitis A Virus, Virology, and Hepatology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Lock to food-borne pathogen pathway may be key to vaccine.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Medicine and the U.S. Department of Agriculture-Agricultural Research Service. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
For more facts and information, see all results

Source: HighBeam Research, Immunization With Alum Allows Manipulation Of T-cell Response.(Brief...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA